Picture of Eledon Pharmaceuticals logo

ELDN — Eledon Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Brief: Novus Therapeutics Reports Q3 2020 Financial Results

Nov 16 (Reuters) - Novus Therapeutics Inc  NVUS.O :
    * NOVUS THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS
    * Q3 LOSS PER SHARE $5.51
    * Q3 EARNINGS PER SHARE ESTIMATE $-1.75 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nBw38zqDNa 
Further company coverage:  NVUS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Eledon Pharmaceuticals

See all news